Increasing Precision in Respiratory Research via Sophisticated Human Challenge Modeling
Next-generation human challenge models are revolutionizing respiratory virus research by delivering controlled, accelerated proof-of-concept data that traditional field trials cannot match.
News & Resources
Beyond Influenza: Measuring Immune Function in Trials
The Biomarker Gold Rush: Are we collecting data just because we can?
.png)
PK/PD: The Operational Engine Behind Early‑Phase Success
From Buffy Coat to Better Clinical Data: Why PBMC Processing Matters
Designing Early‑Phase Trials with Patients in Mind: The Operational Reality
Airflow Obstruction (AFO) in mild, moderate, and severe asthma: associations with small airway disease, clinical characteristics and Type2 biomarkers
What Small Biotechs Get Wrong About First‑in‑Human Trials
Due Diligence as Risk Intelligence
Mock Due Diligence: The Most Important Step Startups Skip
Recruiting for Complex Trials Requires a Different Kind of Engine
In-Person Events
SaxoCell Conference on Cell and Gene Therapy
Explore the Future of Cell and Gene Therapy Development hVIVO will be attending the SaxoCell Conference, a focused ...
Capital Markets Day 2026
The event will provide investors with a deeper understanding of hVIVO's strategic evolution from specialist human ...
11th German Pharm-Tox Summit 2026
The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). The ...
PSI 2026
Join us at the PSI 2026 Conference, taking place 15–17 June at the award‑winning ICC Belfast. This year’s event brings ...
PCMG26
PCMG26 is a leading annual gathering for professionals in pharmaceutical clinical outsourcing, vendor management, and ...
BIO International Convention
hVIVO is proud to be attending BIO International Convention 2026, the world’s largest gathering of biotechnology, ...
American Society for Virology
The American Society for Virology (ASV) is a premier scientific organisation dedicated to advancing the understanding ...
Options XIII
Options XIII is a major global conference dedicated to advancing influenza science, policy, and pandemic preparedness, ...
ERS Congress
The ERS International Congress is one of the world’s leading events in respiratory medicine, bringing together ...
Drug Discovery 2026
Drug Discovery 2026 is a leading UK‑based conference bringing together researchers, biotechs, pharma innovators, and ...
World Vaccine Congress Europe
Meet the Team Accelerate Vaccine Development Through Collaboration and Innovation hVIVO will be attending the World ...
IDWeek 2026
IDWeek 2026 is a premier global meeting for professionals in infectious diseases, epidemiology, infection prevention, ...
Workshops
Workshop: Build Your Target Product Profile With Confidence
Build your Target Product Profile With Confidence For biotech and start‑up teams balancing innovation with speed, a ...
From Preclinical to Clinical: Essential Steps Toward First-In-Human Studies
Practical Solutions for Complex Drug Development The journey from concept to First‑In‑Human (FIH) trials is filled with ...
Inside VC Due Diligence: The Risks Investors Find First
Taking place on the 8th November at 15:00-16:30 CET, this interactive workshop is designed for biotech startups and ...
From Preclinical to Clinical: Essential Steps Toward First-In-Human Studies
Practical Solutions for Complex Drug Development The journey from concept to First‑In‑Human (FIH) trials is filled with ...
Webinar
Getting Biomarkers Right: Strategy, Execution, and Clinical Relevance in Early Drug Development
Biomarkers can play a critical role in early drug development, helping teams understand biological activity, identify ...
On Demand
Choosing The Right Moment For Pre‑IND: Integrating US And EU Regulatory Pathways Into Your Strategy
The FDA Pre‑IND review is often approached as a regulatory checkpoint. However, for early‑stage biotechs, deciding when ...
Fast-Tracking First-In-Human: A Startup-Focused Guide to IND Readiness and Early Clinical Success
Practical guidance for startups navigating IND readiness and early clinical planning. Taking a drug candidate from ...
Smarter Molecular Strategies for Infectious Disease Trials: Turning Complex Data into Clinical Advantage
As infectious disease programs face increasing pressure to generate high-quality data faster, integrated molecular ...
The future of cardiometabolic trials: From obesity to outcomes that matter
As obesity continues to reshape the cardiometabolic landscape, early-stage developers face growing pressure to generate ...
.jpg)
Accelerate your RSV Programme with our RSV Human Challenge Model
About RSV & why developing RSV antivirals and vaccines are critical Respiratory Syncytial Virus (RSV) is a common, ...
Accelerate Your hMPV Programme with hVIVO's Challenge Model
Advancing your Human Metapneumovirus (hMPV) research? Discover how the world's only contemporary-strain hMPV human ...
Technical Due Diligence in Drug Development: What Startup Founders Need to Know to Succeed
Join industry experts for an interactive discussion on mastering technical due diligence. Due diligence is a critical ...